Insiders · PRTK

PRTK insider transactions

Paratek Pharmaceuticals Inc. (PRTK) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

PRTK insiders

Everyone who has filed a Form 4 or 5 at Paratek Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.

• Minnie Baylor-HenryDirector
• Rolf K HoffmannDirector
• Randall B. BrennerOfficer-$454K
• Kristine PetersonDirector
• Jeffrey SteinDirector-$13.3K
• William M. HaskelOfficer-$494K
• Michael BighamOfficer, Director-$932K
• Timothy R FransonDirector-$13.2K
• Adam WoodrowOfficer-$278K
• Evan LohOfficer, Director-$1.41M
• Thomas John DietzDirector
• Robert S RadieDirector
• James D Dondero10% owner+$1.28M

Recent Form 3, 4, and 5 filings for PRTK

• 1142d
  SEC Form 4: Baylor-Henry Minnie returned 59,200 shares to the company, closing all direct ownership in the company

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1142d
  SEC Form 4: Hoffmann Rolf K returned 84,000 shares to the company, closing all direct ownership in the company

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1142d
  SEC Form 4: Brenner Randall B. returned 415,209 shares to the company, closing all direct ownership in the company

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1142d
  SEC Form 4: Peterson Kristine returned 79,000 shares to the company, closing all direct ownership in the company

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1142d
  SEC Form 4: Stein Jeffrey returned 68,625 shares to the company, closing all direct ownership in the company

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1142d
  SEC Form 4: Haskel William M. returned 447,024 shares to the company, closing all direct ownership in the company

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1142d
  SEC Form 4: Bigham Michael exercised 23,255 shares at a strike of $4.30 and returned 1,358,032 shares to the company, closing all direct ownership in the company

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1142d
  SEC Form 4: Franson Timothy R returned 72,000 shares to the company, closing all direct ownership in the company

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1142d
  SEC Form 4: Woodrow Adam returned 749,034 shares to the company, closing all direct ownership in the company

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1142d
  SEC Form 4: Loh Evan returned 1,327,981 shares to the company, closing all direct ownership in the company

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1142d
  SEC Form 4: Dietz Thomas John returned 69,250 shares to the company, closing all direct ownership in the company

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1142d
  SEC Form 4: Radie Robert S returned 73,000 shares to the company, closing all direct ownership in the company

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1184d
  SEC Form 4: Woodrow Adam was granted 98,750 shares, increasing direct ownership by 15% to 750,034 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1184d
  SEC Form 4: Brenner Randall B. was granted 67,500 shares and sold $60,727 worth of shares (27,603 units at $2.20), increasing direct ownership by 11% to 415,209 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1184d
  SEC Form 4: Bigham Michael was granted 156,250 shares and sold $68,750 worth of shares (31,250 units at $2.20), increasing direct ownership by 10% to 1,334,702 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1184d
  SEC Form 4: Haskel William M. was granted 73,750 shares and sold $75,957 worth of shares (34,526 units at $2.20), increasing direct ownership by 10% to 447,024 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1184d
  SEC Form 4: Loh Evan was granted 168,750 shares and sold $107,727 worth of shares (48,967 units at $2.20), increasing direct ownership by 10% to 1,327,981 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1249d
  SEC Form 3: New insider Brenner Randall B. claimed ownership of 40,000 shares (Amendment)

  3/A - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1318d
  SEC Form 4 filed by Dondero James D

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1318d
  SEC Form 3: New insider Dondero James D claimed ownership of 5,903,947 shares

  3 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1352d
  SEC Form 4: Stein Jeffrey sold $13,300 worth of shares (7,000 units at $1.90) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 68,625 units (tax liability)

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1352d
  SEC Form 4: Franson Timothy R sold $13,160 worth of shares (7,000 units at $1.88) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 72,000 units (for withholding tax)

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1365d
  SEC Form 4: Stein Jeffrey was granted 20,000 shares, increasing direct ownership by 36% to 75,625 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1365d
  SEC Form 4: Radie Robert S was granted 20,000 shares, increasing direct ownership by 38% to 72,250 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1365d
  SEC Form 4: Peterson Kristine was granted 20,000 shares, increasing direct ownership by 34% to 79,000 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1365d
  SEC Form 4: Hoffmann Rolf K was granted 20,000 shares, increasing direct ownership by 31% to 84,000 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1365d
  SEC Form 4: Franson Timothy R was granted 20,000 shares, increasing direct ownership by 34% to 79,000 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1366d
  SEC Form 4: Dietz Thomas John was granted 20,000 shares, increasing direct ownership by 40% to 70,000 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1366d
  SEC Form 4: Baylor-Henry Minnie was granted 20,000 shares, increasing direct ownership by 51% to 59,200 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1415d
  SEC Form 4: Woodrow Adam was granted 22,500 shares and sold $13,432 worth of shares (6,750 units at $1.99) as part of a pre-agreed trading plan, increasing direct ownership by 2% to 651,284 units (withholding tax)

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1415d
  SEC Form 4: Loh Evan was granted 52,500 shares and sold $46,743 worth of shares (23,489 units at $1.99) as part of a pre-agreed trading plan, increasing direct ownership by 2% to 1,208,198 units to cover taxes

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1415d
  SEC Form 4: Haskel William M. was granted 15,000 shares and sold $13,944 worth of shares (7,007 units at $1.99) as part of a pre-agreed trading plan, increasing direct ownership by 2% to 407,800 units to satisfy tax liability

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1415d
  SEC Form 4: Brenner Randall B. was granted 15,000 shares and sold $9,033 worth of shares (4,539 units at $1.99) as part of a pre-agreed trading plan, increasing direct ownership by 3% to 335,312 units to satisfy withholding obligation

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1415d
  SEC Form 4: Bigham Michael was granted 45,000 shares and sold $31,342 worth of shares (15,750 units at $1.99) as part of a pre-agreed trading plan, increasing direct ownership by 2% to 1,209,702 units to cover withholding tax

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1423d
  SEC Form 4: Woodrow Adam sold $19,819 worth of shares (10,073 units at $1.97) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 635,534 units (for tax liability)

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1423d
  SEC Form 4: Loh Evan sold $196,267 worth of shares (99,750 units at $1.97) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 1,179,187 units to cover taxes

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1423d
  SEC Form 4: Haskel William M. sold $74,756 worth of shares (37,994 units at $1.97) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 399,807 units to satisfy withholding tax

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1423d
  SEC Form 4: Brenner Randall B. sold $57,615 worth of shares (29,282 units at $1.97) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 324,851 units (for tax liability)

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1423d
  SEC Form 4: Bigham Michael sold $101,085 worth of shares (51,375 units at $1.97) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 1,180,452 units (withholding obligation)

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1466d
  SEC Form 4: Woodrow Adam sold $15,834 worth of shares (4,563 units at $3.47) as part of a pre-agreed trading plan, decreasing direct ownership by 0.70% to 645,607 units to satisfy withholding tax

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1466d
  SEC Form 4: Loh Evan sold $30,553 worth of shares (8,805 units at $3.47) as part of a pre-agreed trading plan, decreasing direct ownership by 0.68% to 1,278,937 units (tax liability)

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1466d
  SEC Form 4: Haskel William M. sold $15,206 worth of shares (4,382 units at $3.47) as part of a pre-agreed trading plan, decreasing direct ownership by 0.99% to 437,801 units to satisfy withholding obligation

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1466d
  SEC Form 4: Brenner Randall B. sold $12,201 worth of shares (3,516 units at $3.47) as part of a pre-agreed trading plan, decreasing direct ownership by 0.98% to 354,133 units (for withholding tax)

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1466d
  SEC Form 4: Bigham Michael sold $20,820 worth of shares (6,000 units at $3.47) as part of a pre-agreed trading plan, decreasing direct ownership by 0.48% to 1,231,827 units (withholding tax)

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1471d
  SEC Form 4: Woodrow Adam was granted 15,000 shares, increasing direct ownership by 2% to 650,170 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1471d
  SEC Form 4: Loh Evan was granted 30,000 shares, increasing direct ownership by 2% to 1,287,742 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1471d
  SEC Form 4: Haskel William M. was granted 9,250 shares, increasing direct ownership by 2% to 442,183 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1471d
  SEC Form 4: Brenner Randall B. was granted 8,500 shares, increasing direct ownership by 2% to 357,649 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1471d
  SEC Form 4: Bigham Michael was granted 30,000 shares, increasing direct ownership by 2% to 1,237,827 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1549d
  SEC Form 4: Woodrow Adam was granted 71,591 shares, increasing direct ownership by 13% to 635,170 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1549d
  SEC Form 4: Loh Evan was granted 152,727 shares and sold $118,421 worth of shares (44,519 units at $2.66) as part of a pre-agreed trading plan, increasing direct ownership by 9% to 1,257,742 units (tax withholding)

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1549d
  SEC Form 4: Haskel William M. sold $59,725 worth of shares (22,453 units at $2.66) as part of a pre-agreed trading plan and was granted 47,727 shares, increasing direct ownership by 6% to 432,933 units (withholding obligation)

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1549d
  SEC Form 4: Brenner Randall B. was granted 47,727 shares and sold $52,157 worth of shares (19,608 units at $2.66) as part of a pre-agreed trading plan, increasing direct ownership by 9% to 349,149 units to satisfy withholding tax

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1549d
  SEC Form 4: Bigham Michael was granted 143,182 shares and sold $76,174 worth of shares (28,637 units at $2.66) as part of a pre-agreed trading plan, increasing direct ownership by 10% to 1,207,827 units (tax withholding)

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1689d
  SEC Form 4: Woodrow Adam was granted 101,250 shares, increasing direct ownership by 22% to 563,579 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1689d
  SEC Form 4: Loh Evan was granted 236,250 shares, increasing direct ownership by 26% to 1,149,534 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1689d
  SEC Form 4: Haskel William M. was granted 67,500 shares, increasing direct ownership by 20% to 407,659 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1689d
  SEC Form 4: Brenner Randall B. was granted 67,500 shares, increasing direct ownership by 27% to 321,030 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1689d
  SEC Form 4: Bigham Michael was granted 202,500 shares, increasing direct ownership by 23% to 1,093,282 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)
• 1722d
  SEC Form 4: Stein Jeffrey was granted 20,000 shares, increasing direct ownership by 56% to 55,625 units

  4 - Paratek Pharmaceuticals, Inc. (0001178711) (Issuer)